Alerts will be sent to your verified email
Verify Email
JFLLIFE
|
JFL Life Sciences
|
Dipna Pharma.
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.26 % | 16.1 % | 4.39 % |
|
5yr average Equity Multiplier
|
2.68 | 14.87 | 2.06 |
|
5yr Average Asset Turnover Ratio
|
0.93 | 1.35 | 0.95 |
|
5yr Avg Net Profit Margin
|
5.75 % | 0.81 % | 2.38 % |
|
Price to Book
|
1.09 | 0.75 | 2.53 |
|
P/E
|
13.02 | 44.77 | 19.04 |
|
5yr Avg Cash Conversion Cycle
|
138.58 Days | -33.62 Days | 75.63 Days |
|
Inventory Days
|
96.42 Days | 62.45 Days | 28.27 Days |
|
Days Receivable
|
135.23 Days | 112.8 Days | 389.8 Days |
|
Days Payable
|
103.44 Days | 139.84 Days | 203.89 Days |
|
5yr Average Interest Coverage Ratio
|
4.03 | 2.01 | 23.53 |
|
5yr Avg ROCE
|
17.72 % | 12.33 % | 6.37 % |
|
5yr Avg Operating Profit Margin
|
10.31 % | 2.41 % | 3.78 % |
|
5 yr average Debt to Equity
|
0.9 | 5.84 | 0.03 |
|
5yr CAGR Net Profit
|
50.43 % | 117.34 % | -14.7 % |
|
5yr Average Return on Assets
|
5.01 % | 1.21 % | 2.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.47 % | 9.98 % | 46.79 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -56.58 % | -0.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
JFL Life Sciences
|
Dipna Pharma.
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|